ArticleCell death & disease2025

Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.

Bengisu Dayanc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.